Cargando…

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling

Detalles Bibliográficos
Autores principales:	Li, Cheng, Yang, Zhenlin, Wu, Yanling, Ying, Tianlei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849146/ https://www.ncbi.nlm.nih.gov/pubmed/36653321 http://dx.doi.org/10.1002/ctm2.1182

Ejemplares similares

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges
por: Quadeer, Ahmed Abdul
Publicado: (2020)

Defining a highly conserved cryptic epitope for antibody recognition of SARS-CoV-2 variants
por: Hao, Aihua, et al.
Publicado: (2023)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

Timely development of vaccines against SARS-CoV-2
por: Lu, Shan
Publicado: (2020)

Multicomponent vaccines to fight SARS-CoV-2 variants of concern
por: Cassone, Antonio, et al.
Publicado: (2021)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants
por: Cevik, Muge, et al.
Publicado: (2021)

Identification of Human Single-Domain Antibodies against SARS-CoV-2
por: Wu, Yanling, et al.
Publicado: (2020)

Bioinformatics approach for the construction of multiple epitope vaccine against omicron variant of SARS-CoV-2
por: Zaib, Sumera, et al.
Publicado: (2022)

Human challenge trials to assess the efficacy of currently approved COVID-19 vaccines against SARS-CoV-2 variants
por: Su, Shan, et al.
Publicado: (2021)

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing
por: Muthumani, Kar, et al.
Publicado: (2021)

Inhalable antibodies for the treatment of COVID-19
por: Yang, Zhenlin, et al.
Publicado: (2022)

The prominent role of a CDR1 somatic hypermutation for convergent IGHV3-53/3-66 antibodies in binding to SARS-CoV-2
por: Tian, Xiaolong, et al.
Publicado: (2022)

Vaccine against SARS-CoV-2 in previously infected health care workers
por: Parisi, Saverio Giuseppe
Publicado: (2021)

Guangdong’s Study of the Effectiveness of China’s Inactivated Vaccines Against the SARS-CoV-2 B.1.617.2 (Delta) Variant
por: Wang, Fuzhen, et al.
Publicado: (2021)

Epitope Identification and Designing a Potent Multi-epitope Vaccine Construct against SARS-CoV-2 Including the Emerging Variants
por: Srinivasan, Sivasubramanian, et al.
Publicado: (2022)

On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties
por: Kritsotakis, Evangelos I.
Publicado: (2020)

The mysterious origins of the Omicron variant of SARS-CoV-2
por: Du, Pei, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Is the Omicron variant of SARS-CoV-2 coming to an end?
por: Zhao, Yingjie, et al.
Publicado: (2022)

Do SARS-CoV-2 Variants Differ in Their Neuropathogenicity?
por: Bauer, Lisa, et al.
Publicado: (2023)

A candidate multi-epitope vaccine against SARS-CoV-2
por: Kar, Tamalika, et al.
Publicado: (2020)

Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants
por: Maltezou, Helena C., et al.
Publicado: (2022)

The potential of developing a protective peptide‐based vaccines against SARS‐CoV‐2
por: Shalash, Ahmed O., et al.
Publicado: (2022)

Role of Omicron variant of SARS-CoV-2 in children in Germany
por: Bittmann, Stefan
Publicado: (2022)

SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant
por: Berkhout, Ben, et al.
Publicado: (2022)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

Reverse vaccinology approach for multi-epitope centered vaccine design against delta variant of the SARS-CoV-2
por: Jalal, Khurshid, et al.
Publicado: (2022)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Is there a post-SARS-CoV-2 vaccination dementia?
por: Fiorini, Ana C., et al.
Publicado: (2022)

Development of multi-epitope peptide-based vaccines against SARS-CoV-2
por: Lim, Hui Xuan, et al.
Publicado: (2021)

Antibody Cocktail Exhibits Broad Neutralization Activity Against SARS-CoV-2 and SARS-CoV-2 Variants
por: Qu, Yuanyuan, et al.
Publicado: (2021)

Public health actions to control new SARS-CoV-2 variants
por: Grubaugh, Nathan D., et al.
Publicado: (2021)

The omicron variant of SARS‐CoV‐2: Understanding the known and living with unknowns
por: Ingraham, Nicholas E., et al.
Publicado: (2021)

Alpha variant SARS-CoV-2 infection: How it all starts
por: Domingo, Pere, et al.
Publicado: (2021)

Omicron variant of SARS-CoV-2 – A new kid on the block
por: Husain, Uneza, et al.
Publicado: (2022)

Landscape and Selection of Vaccine Epitopes in SARS-CoV-2
por: Smith, Christof C., et al.
Publicado: (2020)

Landscape and selection of vaccine epitopes in SARS-CoV-2
por: Smith, Christof C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kt7skdbf2l6uvijtll3mjf7s6l